⚕ GalenOps CRO console
← 716 (USA)

716-1063

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 716 (USA) (Dr. Ito) · consented 2013-05-09
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-01 (study day 54.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-09 (study day 366.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate LETHARGY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-31 (study day 84.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-04 (study day 57.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-07-04 (study day 57.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate RESTLESSNESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-28 (study day 81.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate RESTLESSNESS — outcome: RECOVERED/RESOLVED; onset 2013-07-28 (study day 81.0); relationship: PROBABLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.